Month: August 2023
-
Six start in race for MA Board
- 28 Aug 2023
As nominations open, competition for the three vacancies intensifies and while most MDs are now in or out, a number remain undecided.
Read more -
PBAC cuts price of siRNA siblings
- 28 Aug 2023
While one gets a fast turnaround, the other had to wipe $1B off its price as a discussion paper flags RNA as a growth industry for Australia.
Read more -
ST set to challenge Teva in ALS
- 28 Aug 2023
Specialised Therapeutics in-licenses an oral form of Teva’s recently approved IV therapy for ALS for Australia and NZ.
Read more -
States take aim at PBAC decisions
- 25 Aug 2023
HTA review subs reveal a litany of complaints directed at PBAC while NSW points to Pharmac for its competitive pricing strategy.
Read more -
IGR a case for greater PBS investment
- 25 Aug 2023
New treatments mean Australians live longer, healthier lives, the latest report recommending the government invest in quality outcomes.
Read more -
Novartis double bill lands at TGA
- 25 Aug 2023
Swiss pharma’s ‘pipeline in a pill’ and radioligand commence their TGA journey as Moderna hops on the fast priority track with its mRNA RSV vaccine.
Read more -
Kenvue ANZ is up and running
- 25 Aug 2023
Final separation from J&J makes this the newest kid on the consumer health block, its fledgling local team packed with experience.
Read more -
MedTwos: Nicole and Sean Millis
- 23 Aug 2023
Nicole became a patient advocate to secure a life-saving drug for her son Sean, an actor and a singer who is in this season of The Voice.
Read more








